Another approach is ligand-functionalization, in which nanoparticles are coupled with targeting ligands like aptamers, peptides, or antibodies to enable them to bind specifically to particular receptors on CD4+ T-cells or tumor cells. This evidence concerns the gene CD4 and neoplasm.